Cellular plasticity contributes to the regenerative capacity of plants, invertebrates, teleost fishes and amphibians. In vertebrates, differentiated cells are known to revert into replicating progenitors, but these cells do not persist as stable stem cells. Here we present evidence that differentiated airway epithelial cells can revert into stable and functional stem cells in vivo. After the ablation of airway stem cells, we observed a surprising increase in the proliferation of committed secretory cells. Subsequent lineage tracing demonstrated that the luminal secretory cells had dedifferentiated into basal stem cells. Dedifferentiated cells were morphologically indistinguishable from stem cells and they functioned as well as their endogenous counterparts in repairing epithelial injury. Single secretory cells clonally dedifferentiated into multipotent stem cells when they were cultured ex vivo without basal stem cells. By contrast, direct contact with a single basal stem cell was sufficient to prevent secretory cell dedifferentiation. In analogy to classical descriptions of amphibian nuclear reprogramming, the propensity of committed cells to dedifferentiate is inversely correlated to their state of maturity. This capacity of committed cells to dedifferentiate into stem cells may have a more general role in the regeneration of many tissues and in multiple disease states, notably cancer.
The term dedifferentiation was first coined to describe the process in which cells of the urodele retinal pigment epithelium lose their differentiated properties to replace extirpated lens cells 1 . Although not formally demonstrated, the term was used to suggest that differentiated epithelial cells reverted to a previous developmental stage before their subsequent differentiation into an alternative cell fate. Dedifferentiation has since been explored in plants, invertebrates, teleost fishes and amphibians [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . In vertebrates, quiescent differentiated cells can revert into replicating progenitor cells [5] [6] [7] 11, 12, 14 to replace lost cells, but these progenitor cells do not persist as stable stem cells 11 . Indeed, in murine hair follicle regeneration, the immediate differentiated progeny of epithelial stem cells are already resistant to dedifferentiation 17 . Conversely, the undifferentiated secretory progenitors of the intestine that are the immediate progeny of intestinal stem cells are able to dedifferentiate into stem cells after injury 13 , mimicking the capacity for dedifferentiation of the immediate progeny of Drosophila germline stem cells 3, 15, 16 . Recently, using stringent lineage-tracing strategies 18 , airway epithelial cells have been shown to be more plastic than recognized previously. In a separate study, differentiated secretory cells have been shown to give rise to very rare cells (0.34 6 0.09%) that express basal cell markers after severe injury, but the properties of these rare basal-like cells were not studied and their functional capacity was not assessed 19 . Here, we specifically sought to determine whether stably committed luminal cells could dedifferentiate into functional stem cells.
Secretory cells replicate after stem cell ablation
Airway basal stem cells have been shown to self-renew and differentiate into multiple airway epithelial cell types using genetic lineage tracing 20, 21 . Secretory cells are differentiated luminal cells that have both secretory and detoxifying functions. Secretory cells can also further differentiate into ciliated cells 19 . To test whether secretory cells can dedifferentiate into stem cells, we ablated basal stem cells of the airway epithelium and simultaneously lineage traced the secretory cells of the same mouse (Extended Data Fig. 1 ). To ablate the airway basal stem cells, we generated a CK5-rtTA/tet(O)DTA 22, 23 (hereafter referred to as CK5-DTA) mouse, which expresses the active subunit of the diphtheria toxin (DTA) in CK5 (also known as KRT5) 1 airway basal stem cells following doxycycline administration. CK5 expression is, however, not restricted to the basal stem cells of the airway epithelium and is expressed in many other epithelial tissues 20, 22 . Therefore, the ablation of CK5-expressing cells using systemic doxycycline administration through drinking water or by intraperitoneal injection is lethal in the adult mouse (data not shown). To circumvent this problem, we designed a method for the inhalational delivery of doxycycline 24 as a means of inducing DTA transgene expression exclusively in the airway epithelium. CK5-DTA mice were exposed to either inhaled PBS (i-PBS) or inhaled doxycycline (i-Dox) for two or three consecutive days ( Fig. 1a, b ). Tracheas were isolated 24 h after the final dose of i-Dox. Immunofluorescence analysis using the basal stem cell markers p63 (also known as TP63), CK5, NGFR and T1a (also known as PDPN) demonstrated a specific dose-dependent ablation of basal cells and a preservation of normal secretory cell numbers ( Fig. 1c, d and Extended Data Fig. 2a -c). Approximately 80% (n 5 3) of the airway basal cells were ablated after three doses of inhaled doxycycline (an 81.0 6 3.4% decrease in the number of CK5 1 cells and a 78.8 6 2.4% decrease in the number of p63 1 cells) (Extended Data Fig. 2d ). Immunofluorescence staining of the proliferation marker Ki67 in combination with cell-type-specific markers demonstrated that residual CK5 1 and p63 1 basal cells do proliferate, but there are actually fewer numbers of proliferating basal cells relative to the total population of replicating cells after ablation ( Fig. 1c, e ). Notably, there was a twofold increase in the numbers of replicating secretory cells (SCGB1A1 1 Ki67 1 ) in i-Dox-treated animals (51.29 6 3.02%) as compared to i-PBS-treated animals (17.7 6 2.68%) ( Fig. 1c , e and Extended Data Fig. 3a ). Consistent with the increased proliferation of differentiated secretory cells, Ki67 staining was specifically increased in the CK8 (also known as KRT8) 1 suprabasal layer of the airway epithelium (Extended Data Fig. 3b ). Thus, secretory cells are the predominant cells that replicate after stem cell ablation. Interestingly, occasional cells expressed both the basal cell marker CK5 and the secretory cell marker SCGB1A1 in i-Dox-treated mice (Extended Data Fig. 3c ).
Secretory cells dedifferentiate in vivo
To lineage-label secretory cells before stem cell ablation, we generated quadruple transgenic mice: Scgb1a1-creER/LSL-YFP::CK5-rtTA-tet(O)DTA (hereafter referred to as SCGB1A1-YFP/CK5-DTA mice). Administration of tamoxifen to induce the CreER-mediated expression of the yellow fluorescent protein (YFP) label in secretory cells was followed by three doses of i-Dox to induce basal cell ablation ( Fig. 2a ). Lineage-labelled YFP 1 secretory cells demonstrated increased rates of proliferation in i-Dox-treated animals as compared to i-PBS treated controls (Extended Data Fig. 3d, e ). We identified YFP 1 secretory-cell-derived cells that were morphologically indistinguishable from basal stem cells (Fig. 2b ). In addition, we found that a subset of lineage-labelled cells expressed a suite of basal cell markers including CK5, NGFR, p63 and T1a ( Fig. 2b and Extended Data Fig. 3f ). Quantification revealed that 7.9 6 2.08% of basal cells (585 CK5 1 YFP 1 cells out of 7,320 total CK5 1 cells in i-Dox-treated animals, n 5 6 mice) expressed a YFP lineage label, demonstrating that dedifferentiated basal-like cells comprised a substantial fraction of the total stem cell pool. Dedifferentiated cells did not appear in PBS-treated controls (3 CK5 1 YFP 1 cells out of 7,558 total CK5 1 cells counted (0.041 6 0.028%; n 5 6 mice)). Consistently, when the entire basal cell population is purified by flow cytometry, the YFPlineage-labelled basal-like cells have lost the secretory cell surface marker SSEA-1 ( Fig. 2c ). Thus, dedifferentiating cells lose markers of secretory cell differentiation as they acquire markers of basal stem cells.
Secretory cells dedifferentiate ex vivo
Because our in vivo experiments demonstrated that secretory cells are stimulated to dedifferentiate by the ablation of basal stem cells, we wondered whether secretory cell dedifferentiation could be induced ex vivo when secretory cells were cultured in the absence of basal stem cells. We reasoned that such an assay would provide a platform for further determining whether the dedifferentiation process is actively suppressed by the presence of co-cultured basal stem cells. To assess this possibility, we isolated and sorted unlabelled basal stem cells and YFP 1 secretory cells from SCGB1A1-YFP mice after tamoxifen 
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injection (Extended Data Fig. 4 ). We then performed sphere-forming assays with these pure YFP-labelled secretory cells alone or in combination with pure sorted GSIb4 1 unlabelled basal cells in varying proportions. The formation of three possible types of spheres is predicted to occur, including spheres that are comprised of (1) exclusively YFP 1 secretory-cell-derived cells; (2) exclusively unlabelled basal-cell-derived cells; or (3) chimaeric spheres containing YFP 1 secretory-cell-derived and unlabelled basal-cell-derived cells in the same sphere ( Fig. 3a) . Using our mixed cell populations, we identified a seeding density at which 99.14% 6 0.18 (n 5 3) of spheres were either entirely YFP 1 or entirely unlabelled, thus establishing a clonal origin of the spheres. Regardless of the relative ratio of input secretory and basal stem cells cultured together in a well, the aggregate clonal sphere-forming efficiency of each cell type remained constant (Fig. 3b ).
Immunofluorescence analysis demonstrated that in many spheres originating from a single YFP 1 secretory cell, some YFP 1 cells expressed the basal stem cell markers CK5 and p63, indicating that secretory cell dedifferentiation occurs ex vivo (even in the presence of nearby purely stem-cell-derived spheres; Fig. 3c ). Thus, we established an ex vivo clonal dedifferentiation assay. Of the total spheres derived clonally from YFP 1 secretory cells, 88% showed evidence of dedifferentiation, and in 70.58% of these spheres, more than 10% of cells expressed the stem cell marker CK5. Even when the input proportion of basal cells to secretory cells plated in Matrigel was 100:1, no inhibition of dedifferentiation was observed in the spheres that were clonally derived from secretory cells (data not shown). This suggested the possibility that basal cells in one sphere do not provide a secreted factor to suppress the dedifferentiation of secretory cells in another sphere and that direct contact is required to suppress secretory cell dedifferentiation. Indeed, we observed that in the small fraction (0.86% 6 0.09; n 5 3) of chimaerically derived spheres, not a single YFP 1 -labelled secretory cell dedifferentiated and went on to express basal cell markers ( Fig. 3c ). Therefore a single basal stem cell in direct contact with a secretory cell prevents dedifferentiation. Of note, these findings cannot entirely exclude the possibility that a secreted stem-cell-derived growth factor can locally suppress secretory cell dedifferentiation. However, they do suggest that an intimate association of basal cells and secretory cells would be required to generate sufficient concentrations of a putative secreted dedifferentiation-suppressing activity.
To provide further confirmation that secretory cells can dedifferentiate into basal cells ex vivo, we used mice carrying a doxycyclineinducible basal-cell-specific reporter allele (CK5-rtTA/tet(O)H2BGFP) and sorted SSEA-1 1 /H2B-GFP (in which the human histone H2B coding sequence is fused to the GFP coding sequence) 2 secretory cells from their tracheas (Extended Data Fig. 5a, b) and performed a sphereforming assay. We verified that no GFP 1 cells were present before induction by doxycycline. When doxycycline was administered during the course of sphere formation, the first appearance of H2B-GFP occurred at day 3 of culture, indicating that the secretory cells had been converted into basal-like cells. Immunofluorescence analysis revealed that the resulting H2B-GFP 1 cells also expressed p63 and CK5 (Extended Data Fig. 5c , left panels). The same results were obtained when the sorted SSEA-1 1 /H2B-GFP 2 cells were grown on transwells (Extended Data Fig. 5c , right panels). In addition, secretory cells also dedifferentiated into basal-like cells when we cultured lineage-labelled YFP 1 cells of SCGB1A1-YFP mice on transwell membranes or as spheres (Extended Data Fig. 6a-d ). These ex vivo-dedifferentiated cells could be serially passaged five times in transwell culture or as spheres and retain their expression of basal stem cell markers and their ability to self-renew (Extended Data Fig. 6d, e ). Similarly, cells that had undergone dedifferentiation in vivo could also be passaged as stable stem cells (Extended Data Fig. 6f, g) . Thus, dedifferentiated secretory cells can stably self-renew.
Mature secretory cells resist dedifferentiation
To determine whether all secretory cells have the potential to dedifferentiate or whether only a subset of secretory cells is endowed with this capacity, we attempted to subset this class of epithelial cells. To do so, we made use of a transgenic mouse strain that expresses enhanced green fluorescent protein (eGFP) specifically in secretory cells of the 
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airway epithelium driven by the promoter of the B1 subunit of the vacuolar H(1)-ATPase gene (Atp6v1b1; which we reasoned would be associated with mature secretory cells and hereafter refer to as B1-eGFP) 25, 26 . Co-immunostaining for SSEA-1 and GFP demonstrated the existence of three subpopulations of secretory cells: SSEA-1 1 / GFP 2 , SSEA-1 1 /GFP 1 and SSEA-1 2 /GFP 1 (Extended Data Fig. 7a ). Of note, all GFP 1 cells are SCGB1A1 1 secretory cells and none are CK5 1 basal cells (Extended Data Fig. 7a ). To define the cellular hierarchy of these three subsets of cells, we exposed the airway epithelium of B1-eGFP mice to sulphur dioxide (SO 2 ) injury. In this injury model, SO 2 causes the complete sloughing of only the suprabasal differentiated cells. The remaining basal stem cells are left intact and start replicating within 24 h to give rise to a mature epithelium within 14 days. We found that single-positive SSEA-1 1 cells appeared first on day 4 and then matured into double-positive SSEA-1 1 /GFP 1 cells on day 6 (Extended Data Fig. 7b ) before the formation of any fully mature single-positive B1-eGFP 1 cells evident in the fully mature homeostatic epithelium (Extended Data Fig. 7a , bottom panel, arrowheads). Using B1-eGFP mice, we performed sphere-forming assays with each of the three subsets of secretory cells (Fig. 4a ). Intriguingly, all three subsets of cells formed similar large spheres and all these spheres contained basal-like cells ( Fig. 4b-d ). Interestingly, the sphere-forming ability of the three populations was inversely proportional to the relative maturity of the secretory cell subsets ( Fig. 4d ). Of note, most of the cell aggregates produced from the most mature SSEA-1 2 /GFP 1 secretory cell subset occurred as small cell clusters instead of spheres ( Fig. 4c, e ). Furthermore, these cell clusters did not contain CK5-or p63-expressing basal stem cells (Fig. 4c ).
Dedifferentiated cells stably persist
To assess whether dedifferentiated stem-cell-like cells have the ability to self-renew and persist in vivo, we generated SCGB1A1-YFP/CK5-DTA mice that possessed lineage-labelled dedifferentiated basal-like cells as above and these mice were then maintained for 2 months before euthanization (Extended Data Fig. 8a ). Dedifferentiated YFP 1 CK5 1 cells persisted and continued to represent a sizeable fraction of the stem cell pool (9.15% 6 0.41; n 5 3). The relative pool size of dedifferentiated basal-like cells remained stable over the course of 2 months (dedifferentiated basal cells represented 8% of the stem cell pool immediately after dedifferentiation). In addition, triple immunostaining for CK5, YFP and Ki67 revealed that YFP 1 CK5 1 dedifferentiated basal-like cells have the same self-renewal rates as do their normal YFP 2 CK5 1 basal stem cell counterparts (Extended Data Fig. 8b, c) .
Dedifferentiated cells are functional stem cells
To assess the functional stem cell capacity of dedifferentiated basallike cells, we generated SCGB1A1-YFP/CK5-DTA mice that possessed lineage-labelled dedifferentiated basal-like cells and then exposed these animals to two forms of physiologic airway injury (Fig. 5a, b ). First, a toxin-induced airway injury with inhaled SO 2 was used to efficiently denude suprabasal cells from the airway epithelium, leaving behind a single layer of basal cells, some of which were derived from labelled secretory cells that had dedifferentiated (marked by YFP) (Extended Data Fig. 9a ). The epithelium fully regenerated in 14 days as expected and immunofluorescence analysis for YFP in combination with CK5 (basal cell), SCGB1A1 (secretory cell) and FOXJ1 (ciliated cell) revealed that YFP 1 cells contributed to all three epithelial cell lineages in the form of scattered YFP 1 patches (Fig. 5c, top panels) . To further scrutinize the functional potential of our dedifferentiated basal-like cells, we used influenza viral infection as a second physiologic injury model (Extended Data Fig. 9b) 27 . We again observed that dedifferentiated basal-like cells participate in regeneration by giving rise to all three epithelial cell types of the airway (Fig. 5c, bottom panels) . Similarly, sorted dedifferentiated cells that were produced either in vivo or ex vivo could be serially passaged in culture and differentiated into mature airway epithelium (Fig. 5d-f and Extended Data Fig. 10a-c) .
Furthermore, we asked whether individual dedifferentiated basallike cells are multipotent (that is, able to give rise to ciliated, secretory and basal cells) or unipotent (that is, able to give rise to only one of the cell types). To address this issue, we cultured individual dedifferentiated cells and then performed an air-liquid interface culture using these clonally derived stem cells. Immunofluorescence analyses for basal, secretory and ciliated cell markers revealed that most of the clonally derived basal-like cells (11 out of 13 clones) are multipotent (Extended Data Fig. 10d ). Intriguingly, rare clones give rise to only 
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ciliated (1 out of 13 clones) or secretory cells (1 out of 13 clones). The potential of single dedifferentiated cells to act as multipotent stem cells suggests that some or most basal stem cells in vivo may analogously serve as multipotent stem cells. However, the rare lineage restricted clones we observe may reflect a heterogeneity in the basal cell population in vivo that warrants future scrutiny.
Discussion
Here, using lineage tracing, we have presented evidence that fully differentiated cells can revert into stable and functional basal stem cells. By contrast, in the hair follicle, the committed progeny of skin stem cells do not revert into stem cells when the skin stem cells are ablated 17 . However, in the murine intestinal epithelium, undifferentiated secretory progenitors that are the immediate villin-negative progeny of stem cells can revert back to a stem cell state after injury 13 . Notably, the capacity of fully differentiated villin-positive intestinal secretory cells to revert into stem cells was not assessed. Here we show that fully committed secretory cells respond to stem cell ablation by proliferating and converting into functional epithelial stem cells. Our study points to an alternative cellular mechanism through which tissues can regenerate after stem cell loss. The existence of multiple cellular reservoirs of regenerative capacity may allow a more effective reparative response when one or the other cell type is damaged by a toxic or infectious insult.
The ability of basal stem cells to prevent the dedifferentiation of secretory cells has many implications for tissue biology in general, as stem cells and their progeny can now be seen to reciprocally modulate one another to regulate their relative ratios and thereby overall tissue architecture. In our example, the prevention of secretory cell dedifferentiation occurs through direct contact, even with a single stem cell. This mechanism ensures a precise and local control of epithelial architecture. More generally, it suggests that the reciprocal interactions of stem and committed cells may have been 'designed' to ensure a robust self-organizing property in diverse tissue types.
Furthermore, the ability of differentiated cells to acquire stem cell properties seems to be inversely proportional to the degree of the maturity of the differentiated cells. This is analogous to the results seen in amphibian nuclear reprogramming in which nuclei from more mature cells were less easily reprogrammed than those of their immature counterparts 28, 29 . The capacity to segregate secretory cells according to their maturity and associated ability to resist dedifferentiation provides an ideal in vivo experimental model for dissecting the molecular mechanisms through which cells might lock their identity as they mature. Finally, our findings have broad implications for cancer biology, as our results point to an underlying physiologic form of cell plasticity that could be co-opted in the process of tumorigenesis [30] [31] [32] [33] [34] . Indeed, some lung cancers seem to be able to resist chemotherapy by using a lineage conversion into a different tumour subtype 35 .
METHODS SUMMARY
CK5-rtTA 22 , Scgb1a1-creER 19 , tet(O)DTA 23 and B1-eGFP 25,26 mice were described previously. Corn oil or tamoxifen (2 mg per 20 g body weight) were intraperitoneally injected for five consecutive days. Aerosolized PBS or doxycycline was administered by inhalation 24 . SO 2 injury models have been reported previously 19 . Mice were anesthetized and infected with a sublethal dose of influenza by intranasal inhalation as described previously 27 . Sphere culture and staining was performed as described previously 20 . Immunofluorescence and cell sorting were performed using standard protocols.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Mouse models. CK5-rtTA 22 , Scgb1a1-creER 19 , tet(O)DTA 23 and B1-eGFP 25,26 mice were described previously. Rosa26R-eYFP (Gt(Rosa)26Sor tm1(eYFP)Cos) /J) mice (stock no. 006148) and Tg(tet(O)HIST1H2BJ/GFP)47Efu/J; (stock no. 005104) were purchased from The Jackson Laboratory. CK5-rtTA females were crossed to tet(O)DTA males to generate a double-transgenic mouse (CK5-DTA) that expresses DTA protein upon doxycycline administration. Aerosolized doxycycline or PBS was administered as described previously 24 . For secretory cell lineage tracing after basal cell ablation, we crossed male Scgb1a1-creER/Rosa26R-YFP to CK5-DTA female mice to generate quadruple (SCGB1A1-YFP/CK5-DTA)transgenic mice. To label secretory cells, we injected tamoxifen intraperitoneally (2 mg per 20 g body weight) for five consecutive days to induce the Cre-mediated excision of a stop codon and subsequent expression of YFP. Both male and female mice were used for experiments. 6-12-week-old mice were used for experiments. Similar aged mice were used for both control and treated animals. We analysed at least three mice per condition in each experiment. The MGH Subcommittee on Research Animal Care approved animal protocols in accordance with NIH guidelines. SO 2 and influenza infection induced injury. SO 2 injury models have been previously reported 19 . In brief, mice were exposed to 500 p.p.m. of SO 2 for 3 h 40 min. For influenza experiments, influenza A/Puerto Rico/8/34 (PR8) was obtained from Charles River Laboratories International. Mice were anaesthetized and infected with a sublethal dose of influenza by intranasal inhalation as described previously 27 . Mice were killed at day 3 or 14 after infection, and the tracheas were removed and placed in 4% paraformaldehyde (PFA).
Immunofluorescence, microscopy and cell counting. Tracheae were dissected and fixed in 4% PFA for 2 h at 4 uC followed by two washes in PBS, and then embedded in OCT. Cryosections (6 mm) were permeabilized with 0.1% Triton X-100 in PBS, blocked in 1% BSA for 30 min at room temperature (27 uC) , incubated with primary antibodies for 1 h at room temperature, washed, incubated with appropriate secondary antibodies diluted in blocking buffer for 1 h at room temperature, washed and counterstained with DAPI. Spheres were fixed with 4% PFA on day 9 after plating and washed with PBS and stained as described above.
The following primary antibodies were used: chicken anti-GFP (1:500; GFP-1020, Aves Labs); rabbit anti-Ki67 (1:200; ab15580, Abcam); rat anti-Ki67 (1:200; 14-5698-82, eBioscience); goat anti-SCGB1A1 (1:500; provided by B. Stripp); mouse anti-p63 (1:100; sc-56188, Santa Cruz); mouse anti-tubulin, acetylated (1:100; T6793, Sigma); mouse anti-FOXJ1 (1:500; 14-9965, eBioscience), rabbit anti-NGFR (1:200; ab8875, Abcam); mouse IgM anti-SSEA-1 (1:100; 14-8813-82, eBioscience); hamster anti-T1a (1:50, DSHB) and rabbit anti-cytokeratin 5 (1:1,000; ab53121, Abcam). All secondary antibodies were Alexa Fluor conjugates (488, 594 and 647) and used at 1:500 dilution (Life Technologies).
Images were obtained using Olympus IX81 Inverted microscope (Olympus). Confocal images were obtained with a Nikon A1 confocal laser-scanning microscope with a 403 or 603 oil objective (Nikon CFI Plan APO VC 403 or 603 Oil). Cells were manually counted based on immunofluorescence staining of markers for each of the respective cell types. Cartilage 1 to 9 was used as reference points in all the tracheal samples to count specific cell types on the basis of immunostaining. Serial sections were stained for the antibodies tested and randomly selected slides were used for cell counting. Percentage of basal cells per sphere was calculated based on CK5 immunostaining. Spheres with less than 2% CK5 1 cells were not included in the quantification. Cell dissociation and sorting. Airway epithelial cells from trachea were dissociated using papain solution. Longitudinal halves of the trachea were cut into five pieces and incubated in papain dissociation solution and incubated at 37 uC for 2 h. After incubation, dissociated tissues were passed through a cell strainer and centrifuged and pelleted at 500g for 5 min. Cell pellets were dispersed and incubated with Ovo-mucoid protease inhibitor (Worthington biochemical Corporation, cat. no. LK003182) to inactivate residual papain activity by incubating on a rocker at 4 uC for 20 min. Cells were then pelleted and stained with EPCAM-PECy7 (1:50; 25-5791-80, eBioscience) or EPCAM-APC (1:50; 17-5791, eBioscience), GSIb4 (Griffonia Simplicifolia isolectin beta 4)-Biotin (L2120, Sigma), SSEA-1 eFluor 650NC (1:75, 95-8813-41, eBioscience) and PE anti-mouse CD24 (1:100, 553262, BD Pharmingen) for 30 min in 2.5% FBS in PBS on ice. After washing, cells were sorted on BD FACS Aria (BD Biosciences) using FACS Diva software and analysis was performed using FlowJo (version 10) software. Sphere-forming assays and transwell cultures. Cells were cultured and expanded in complete SAGM (small airway epithelial cell growth medium; Lonza, CC-3118) containing TGF-b/BMP4/WNT antagonist cocktails and 5 mM Rock inhibitor Y-27632 (Selleckbio, S1049). To initiate air-liquid interface cultures, airway basal stem cells were dissociated and seeded onto transwell membranes. After confluence, media was removed from the upper chamber. Mucocilary differentiation was performed with PneumaCult-ALI Medium (StemCell, 05001). Differentiation of airway basal stem cells on an air-liquid interface was followed by directly visualizing beating cilia in real time after 10-14 days. For clonal culture assays, dedifferentiated basal-like cells (GSIb4 1 YFP 1 ) were sorted and plated on collagen-coated plates at low cell density to obtain individual colonies. Individual colonies were isolated using microscopic visualization of single colonies followed by trypsin treatment and pipette-assisted aspiration. Individual colony-derived cells were maintained and expanded separately and used for air-liquid interface culture. Sphere culture was performed as described previously 20 . In brief, 50 ml of 1:4 cold Matrigel/ MTEC-plus medium was layered on an 8-well chamber slide (Thermo Scientific, cat. no. 177402) and incubated at 37 uC for 10 min to solidify the Matrigel. Sorted cells were mixed in 2% Matrigel in MTEC-plus and plated on pre-coated 8-well chamber slide at a density of 4,000 cells per well. For mixing assays, sorted cells were seeded at a density of 6,000 cells per well. In each experiment, three independent wells were used for each condition tested. Medium was changed every other day for 9 days. For transwells cultures, cells were suspended in MTEC-plus medium and plated on transwell inserts at a cell density of 6,000 cells per well. Medium was changed every day for 7 days. For basal-cell reporter assays, cells were treated with 1 mg ml 21 doxycycline either at 24 h after plating or just 24 h before collection. For serial passaging of spheres, medium from culture wells was aspirated, washed with PBS, and then treated with trypsin-EDTA (0.25%) for 2 min. Trypsin was inactivated and dissociated cells were collected and centrifuged at 350g for 3 min at 4 uC. Cells were re-seeded at a 1:20 dilution in Matrigel for the next round of sphere culture. Statistical analysis. The standard error of the mean was calculated from the average of at least three independent tracheal samples unless otherwise mentioned. Data were compared among groups using the Student's t-test (unpaired, two-tailed). A P value of less than 0.05 was considered significant.
RESEARCH ARTICLE
